Jupiter Neurosciences Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Jupiter Neurosciences, Inc. (JUNS) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Current Assets
Cash and Cash Equivalents3.770.030.060.330.21
Cash & Short-Term Investments3.770.030.060.330.21
Accounts Receivable0.000.000.000.000.13
Inventory0.000.000.000.000.00
Other Current Assets0.880.000.010.120.00
Total Current Assets4.650.030.070.450.55
Non-Current Assets
Property, Plant & Equipment (Net)0.070.120.160.210.00
Other Non-Current Assets1.480.000.000.000.00
Total Non-Current Assets1.550.120.170.210.00
Total Assets6.200.150.240.670.55
Current Liabilities
Accounts Payable0.280.190.190.260.25
Short-Term Debt0.202.021.730.440.00
Accrued Liabilities0.121.970.394.593.90
Other Current Liabilities1.531.540.710.350.00
Total Current Liabilities2.015.777.265.684.26
Non-Current Liabilities
Long-Term Debt0.020.110.120.160.00
Other Non-Current Liabilities0.000.000.000.000.00
Total Non-Current Liabilities0.020.180.120.160.00
Total Liabilities2.035.957.385.854.26
Stockholders' Equity
Common Stock0.000.000.000.000.00
Retained Earnings-26.02-23.58-18.80-13.84-9.64
Accumulated Other Comprehensive Income0.000.000.000.00-0.50
Additional Paid-in Capital30.1917.7811.658.660.00
Shares Outstanding33.100.000.0033.100.00
Total Stockholders' Equity4.17-5.80-7.14-5.18-3.71
Total Liabilities & Equity6.200.150.240.670.00